Alexion Pharmaceuticals, Inc. (ALXN) News

Alexion Pharmaceuticals, Inc. (ALXN): $182.50

3.05 (+1.70%)

POWR Rating

Component Grades

Momentum

N

Stability

N

Sentiment

Quality

N

Add ALXN to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked


in industry

Filter ALXN News Items

ALXN News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

ALXN News Highlights

  • 500 - Internal server error
  • Over the past 24 days, the trend for ALXN's stories per day has been choppy and unclear. It has oscillated between 1 and 10.
  • The most mentioned tickers in articles about ALXN are MRNA, AZN and MG.

Latest ALXN News From Around the Web

Below are the latest news stories about Alexion Pharmaceuticals Inc that investors may wish to consider to help them evaluate ALXN as an investment opportunity.

AstraZeneca's Acquisition of Alexion Is Nearly a Done Deal, But Is It a Good Deal?

AstraZeneca (NASDAQ: AZN) hopes to soon close its planned acquisition of Alexion Pharmaceuticals (NASDAQ: ALXN). In this Motley Fool Live video recorded on July 7, Motley Fool contributors Keith Speights and Brian Orelli discuss whether or not the Alexion acquisition is a good deal for AstraZeneca. Keith Speights: AstraZeneca has experienced multiple problems with the launch of its COVID-19 vaccine and we're not going to get into all of those problems but there's more news non-COVID related for AstraZeneca now.

Yahoo | July 17, 2021

With the Alexion Acquisition Set to Close This Quarter, Is AstraZeneca a Buy?

With UK approval, the $39 billion deal for rare disorders biotech company Alexion Pharmaceuticals is set to close on July 21.

Yahoo | July 17, 2021

MRNA Stock: 10 Things to Know About Moderna as It Gets Ready to Join the S&P 500

Moderna (MRNA) stock is on the rise Friday as the company prepares to join the S&P 500 next week replacing Alexion Pharmaceuticals (ALXN).

William White on InvestorPlace | July 16, 2021

What Did the Stock Market Do Today? 3 Big Stories to Catch Up On.

What did the stock market do today?

Brenden Rearick on InvestorPlace | July 16, 2021

When Will Moderna Be Added to the S&P 500?

Moderna is joining the S&P 500 on July 21, replacing Alexion Pharmaceuticals.

The Street | July 16, 2021

MRNA Surges to Record High on Plans to Join S&P 500

Moderna stock is set to join the benchmark on July 21, replacing Alexion Pharmaceuticals

Schaeffers Investment Research | July 16, 2021

Alexion''s Ultomiris Shows Compelling, Durable Efficacy In Rare Muscle Weakness Disorder

Alexion Pharmaceuticals Inc (NASDAQ: ALXN ) announced topline results from a Phase 3 study evaluating Ultomiris (ravulizumab-cwvz) in adults with generalized myasthenia gravis (gMG). The study met its primary endpoint, with a statistically significant change in MG-ADL score from baseline through Week 26 for Ultomiris compared to placebo (-3.1 versus -1.4). Myasthenia Gravis-Activities of Daily Living Profile (MG-ADL) Full story available on Benzinga.com

Benzinga | July 16, 2021

Why Moderna Shares Are Rallying Today

Shares of COVID-19 vaccine company Moderna, Inc. (NASDAQ: MRNA ), which ended Thursday''s session with a market cap of $104.3 billion by virtue of a 5.28% rally, are seeing follow-through buying interest Friday. Standard & Poor''s announced late Thursday Moderna will join the S&P 500 Index, effective before the market opens Wednesday, July 21. Moderna will replace Alexion Pharmaceuticals, Inc. (NASDAQ: Full story available on Benzinga.com

Benzinga | July 16, 2021

Moderna Stock, Soon To Join S&P 500, Rockets To Another Record High

The post Moderna Stock, Soon To Join S&P 500, Rockets To Another Record High appeared on BitcoinEthereumNews.com . Moderna stock rocketed to another record high on Friday on news it will join the S&P 500 on Wednesday, replacing soon-to-be-acquired Alexion Pharmaceuticals (ALXN). X The swap will occur when

Bitcoin Ethereum News | July 16, 2021

Alexion (ALXN) Reports Positive Data on Ultomiris From gMG Study

Alexion (ALXN) announces that the phase III study of Ultomiris for the indication of gMG met its primary goal.

Yahoo | July 16, 2021


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!